"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
This study is recruiting in the United States. It is testing a Deuterated Psilocin Analog for depression.
Multiple locations, including Phoenix
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United States. It is testing a Deuterated Psilocin Analog for depression.
Multiple locations, including PhoenixThis study is recruiting. It focuses on anxiety and currently lists participation information in Turkey.
In ErzurumThis study is recruiting. It focuses on anxiety and currently lists participation information in Turkey.
In KirikkaleThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Canada.
In TorontoThis study is recruiting in the United States. It uses PET imaging to look at PDE4B in people with depression.
In BethesdaThis study is recruiting. It focuses on depression and currently lists participation information in Denmark.
In CopenhagenThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Germany.
In MunichThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In Salt Lake CityThis study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
In OxfordThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In GainesvilleThis study is recruiting. It focuses on schizophrenia and currently lists participation information in China.
In BeijingThis study is recruiting in the United Kingdom. It is testing Binding of MSP-2020 to Serotonin 5-HT2A Receptors for Depression.
In London